A solution to the dilution: The role for biomarkers in advanced ovarian cancer

Katelyn F. Handley, Anil K. Sood

Research output: Contribution to journalArticle

Abstract

Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.

Original languageEnglish (US)
Pages (from-to)9-10
Number of pages2
JournalClinical Cancer Research
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2020

Fingerprint

Ovarian Neoplasms
Biomarkers

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A solution to the dilution : The role for biomarkers in advanced ovarian cancer. / Handley, Katelyn F.; Sood, Anil K.

In: Clinical Cancer Research, Vol. 26, No. 1, 01.01.2020, p. 9-10.

Research output: Contribution to journalArticle

@article{b744d34787694fe68b6e91570590feb7,
title = "A solution to the dilution: The role for biomarkers in advanced ovarian cancer",
abstract = "Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.",
author = "Handley, {Katelyn F.} and Sood, {Anil K.}",
year = "2020",
month = "1",
day = "1",
doi = "10.1158/1078-0432.CCR-19-3072",
language = "English (US)",
volume = "26",
pages = "9--10",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - A solution to the dilution

T2 - The role for biomarkers in advanced ovarian cancer

AU - Handley, Katelyn F.

AU - Sood, Anil K.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.

AB - Reliable approaches to predict residual disease prior to primary debulking surgery have been sought to further personalize surgical approaches. Reliance on molecular biomarkers alone in a complex clinical environment is challenging and algorithms that incorporate both molecular and clinical features may need to be considered.

UR - http://www.scopus.com/inward/record.url?scp=85077476072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077476072&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-19-3072

DO - 10.1158/1078-0432.CCR-19-3072

M3 - Article

C2 - 31672769

AN - SCOPUS:85077476072

VL - 26

SP - 9

EP - 10

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 1

ER -